Abstract:In medicine, nanotechnology has sparked a rapidly growing interest as it promises to solve a number of issues associated with conventional therapeutic agents, including their poor water solubility (at least, for most anticancer drugs), lack of targeting capability, nonspecific distribution, systemic toxicity, and low therapeutic index. Over the past several decades, remarkable progress has been made in the development and application of engineered nanoparticles to treat cancer more effectively. For example, therapeutic agents have been integrated with nanoparticles engineered with optimal sizes, shapes, and surface properties to increase their solubility, prolong their circulation half-life, improve their biodistribution, and reduce their immunogenicity. Nanoparticles and their payloads have also been favorably delivered into tumors by taking advantage of the pathophysiological conditions, such as the enhanced permeability and retention effect, and the spatial variations in the pH value. Additionally, targeting ligands (e.g., small organic molecules, peptides, antibodies, and nucleic acids) have been added to the surface of nanoparticles to specifically target cancerous cells through selective binding to the receptors overexpressed on their surface. Furthermore, it has been demonstrated that multiple types of therapeutic drugs and/or diagnostic agents (e.g., contrast agents) could be delivered through the same carrier to enable combination therapy with a potential to overcome multidrug resistance, and real-time readout on the treatment efficacy. It is anticipated that precisely engineered nanoparticles will emerge as the next-generation platform for cancer therapy and many other biomedical applications.

Engineered Nanomedicines with Enhanced Tumor Penetration

Enhancing Drug Penetration in Solid Tumors Via Nanomedicine: Evaluation Models, Strategies and Perspectives

Strategies to improve tumor penetration of nanomedicines through nanoparticle design

Recent Advances in Drug Delivery Systems for Enhancing Drug Penetration into Tumors

Barrier permeation and improved nanomedicine delivery in tumor microenvironments

Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma q

Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management

Engineering nanoparticles to tackle tumor barriers

Size Shrinkable Drug Delivery Nanosystems and Priming the Tumor Microenvironment for Deep Intratumoral Penetration of Nanoparticles

The progress and perspective of strategies to improve tumor penetration of nanomedicines

Engineered Nanoparticles for Drug Delivery in Cancer Therapy

Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery

Nano-engineering nanomedicines with customized functions for tumor treatment applications

Applications of Surface Modification Technologies in Nanomedicine for Deep Tumor Penetration

Advanced Engineered Nanoparticulate Platforms to Address Key Biological Barriers for Delivering Chemotherapeutic Agents to Target Sites.

Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery

Transcytosis of Nanomedicine for Tumor Penetration.

Anticancer nanomedicines harnessing tumor microenvironmental components

Nanoparticle Design Strategies for Enhanced Anticancer Therapy by Exploiting the Tumour Microenvironment.

Nanoparticle-Mediated Transcytosis in Tumor Drug Delivery: Mechanisms, Categories, and Novel Applications

Nanomedicine Disrupts Stromal Barriers to Augment Drug Penetration for Improved Cancer Therapy